LYKERA BIOMED SA has a total of 18 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MABVAX THERAPEUTICS INC, FREDAX AB and GAMAMABS PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | United States | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms | |
#6 | Microorganisms | |
#7 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Calvis Calpe Carme | 12 |
#2 | Mitjans Prat Francesc | 12 |
#3 | Adan Plana Jaume | 12 |
#4 | Roque Navarro Lourdes Tatiana | 11 |
#5 | Messeguer Peypoch Ramon | 11 |
#6 | Coll Manzano Antonio | 11 |
#7 | Dakhel Plaza Sheila | 11 |
#8 | Gomez Casajus Luis Angel | 9 |
#9 | Masa Alvarez Marc | 8 |
#10 | Hernandez Miguez Jose Luis | 8 |
Publication | Filing date | Title |
---|---|---|
WO2012098124A1 | Antibodies against the s100p protein for the treatment and diagnosis of cancer | |
WO2012062777A1 | CYCLIC RGD PEPTIDES OF AMINO ACIDS BASED ON THIAZOLES OR OXAZOLES AS SELECTIVE ANTAGONISTS OF THE ALFA ανβ3 INTEGRIN | |
NZ604643A | S100a4 antibodies and therapeutic uses thereof | |
WO2012139628A1 | Coding polypurine hairpins for the treatment of cancer |